dr. somer on hesitancy regarding biosimilar use in oncology
Published 4 years ago • 39 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
0:57
dr. somer on the expansion of biosimilars in oncology
-
1:46
dr. somer on lowering the cost of cancer care with biosimilars
-
1:50
dr. somer on education for biosimilars
-
0:58
dr. hurvitz on the clinical use of biosimilars in oncology
-
0:53
dr. schmid on evaluating biosimilars in oncology
-
1:48
dr. markman on the concept of biosimilars in oncology
-
0:57
dr. brufsky on biosimilars being explored in oncology
-
1:44
dr. schmid on challenges concerning biosimilars in oncology
-
51:06
biosimilars and oncology clinical pathways: perfect together
-
0:44
dr. hamilton on the impact of biosimilars in oncology
-
1:17
dr. lyman on educating physicians about biosimilars in oncology
-
0:45
dr. preeshagul on education for biosimilars in oncology
-
0:54
dr. brufsky discusses reasons to use biosimilars in oncology
-
1:05
dr. schwartzberg on increasing competition with biosimilars in oncology
-
0:55
dr. slamon discusses the future of biosimilars in oncology
-
0:49
dr. robson discusses differences between biosimilars and biologics in oncology
-
1:42
dr. verma discusses challenges with biosimilars in oncology
-
5:56
the complexity of choosing biosimilars in oncology
-
1:56
dr. schwartzberg on the use of therapeutic biosimilars in breast cancer